RecruitingPhase 3NCT06439563

Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers

A Multicenter, Parallel, Double-blind, Randomized, Active-controlled, Non-inferiority, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 Treatment in the Prevention of (NSAIDs)-Induced Peptic Ulcers

Sponsor

Onconic Therapeutics Inc.

Enrollment

364 participants

Start Date

Oct 22, 2024

Study Type

INTERVENTIONAL

Conditions

Peptic Ulcer

Summary

The sutdy aims to to demonstrate the non-inferiority of JP-1366 10 mg compared to Lanston Capsule 15 mg in preventing NSAIDs-induced peptic ulcers and to compare/evaluate the efficacy and safety of JP-1366 10 mg.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called JP-1366 10 mg, a drug called JP-1366 10 mg placebo, and others for people with peptic ulcer. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGJP-1366 10 mg

JP-1366 10 mg, tablet, orally once a day for up to 24 weeks

DRUGLanston Capsule 15 mg

Lanston Capsule 15 mg orally once a day for up to 24 weeks

DRUGJP-1366 10 mg placebo

JP-1366 10 mg placebo, tablet, orally once a day for up to 24 weeks

DRUGLanston Capsule 15 mg placebo

Lanston Capsule 15 mg placebo, orally once a day for up to 24 weeks

Locations(1)

Konkuk University Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06439563

Related Trials

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

NCT071393661 location

Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease

NCT072600061 location

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

NCT062848762 locations